Search by Drug Name or NDC

    NDC 00169-3201-90 Fiasp 100 [iU]/mL Details

    Fiasp 100 [iU]/mL

    Fiasp is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN ASPART.

    Product Information

    NDC 00169-3201
    Product ID 0169-3201_133d5f6e-b40f-47b6-ab47-10dc37114d79
    Associated GPIs 27104002202020
    GCN Sequence Number 077138
    GCN Sequence Number Description insulin aspart (niacinamide) VIAL 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 43054
    HICL Sequence Number 044099
    HICL Sequence Number Description INSULIN ASPART (NIACINAMIDE)
    Brand/Generic Brand
    Proprietary Name Fiasp
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin aspart injection
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN ASPART
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA208751
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-3201-90 (00169320190)

    NDC Package Code 0169-3201-90
    Billing NDC 00169320190
    Package 1 VIAL, GLASS in 1 CARTON (0169-3201-90) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2017-10-20
    NDC Exclude Flag N
    Pricing Information N/A